bromodeoxyuridine has been researched along with Leukemia, Myeloid in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (44.44) | 18.7374 |
| 1990's | 10 (55.56) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlson, J; Keoffler, HP; Yen, J | 1 |
| Lotem, J; Sachs, L | 2 |
| Borgström, GH; de la Chapelle, A; Elonen, E; Knuutila, S; Kovanen, R; Siimes, M; Vuopio, P | 1 |
| Horiguchi-Yamada, J; Hoshina, S; Nagai, M; Nakada, S; Nemoto, T; Ochi, K; Takahara, S; Yamada, H | 1 |
| Dameron, S; Gregory, S; Iftikhar, A; Loew, J; Marcus, B; Mundle, S; Raza, A; Shetty, V; Wright-Quinones, V | 1 |
| Barcos, M; Gartside, P; Kukla, C; Lampkin, B; Lykins, J; Preisler, H; Raza, A; Sheikh, Y; White, M; Yousuf, N | 1 |
| Belloc, F; Bernard, P; Boisseau, M; Cony-Makhoul, P; Dumain, P; Lacombe, F; Puntous, M; Reiffers, J | 1 |
| Averbeck, D; Bettaïeb, A; Bonnet, J; Bruno, AP; Demur, C; Jaffrézou, JP; Laurent, G; Levade, T | 1 |
| Horiuchi, M; Ichikawa, Y; Maeda, M | 1 |
| Ichikawa, Y; Nagata, K | 1 |
| Anderson, J; Bennett, J; Browman, G; Gezer, S; Goldberg, J; Larson, R; Lykins, J; Preisler, HD; Raza, A; Vogler, R | 1 |
| Contreas, G; Falaschi, A; Giacca, M | 1 |
| Christensen, IJ; Christiansen, J; Larsen, JK; Mortensen, BT | 1 |
| Aglietta, M; Aloe Spiriti, MA; Apra, F; Bianchi, AC; De Felice, L; Petti, MC; Piacibello, W; Sanavio, F; Stacchini, A; Stern, AC | 1 |
| Berger, T; Crone, K; Gray, J; Lampkin, B; Mazewski, C; Miller, MA; Raza, A; Reising, J; Sawaya, R; Sheikh, Y | 1 |
| Hecht, F; Morgan, R; Morgan, SS | 1 |
| Mayers, G; Preisler, HD; Raza, A; Ucar, K | 1 |
2 trial(s) available for bromodeoxyuridine and Leukemia, Myeloid
| Article | Year |
|---|---|
Influence of rhGM-CSF on Ara-C sensitivity of patients with acute myeloid leukemia in relapse: a flow cytometry study.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cell Cycle; Cytarabine; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Male; Middle Aged; Prognosis; Recombinant Proteins; S Phase | 1996 |
Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study.
Topics: Acute Disease; Bone Marrow; Bromodeoxyuridine; Cytarabine; DNA, Neoplasm; Dose-Response Relationship, Drug; Humans; Leukemia, Myeloid; S Phase; Tritium; Tumor Cells, Cultured | 1992 |
16 other study(ies) available for bromodeoxyuridine and Leukemia, Myeloid
| Article | Year |
|---|---|
The study of human myeloid differentiation using bromodeoxyuridine (BrdU).
Topics: Bromodeoxyuridine; Cell Differentiation; Cell Line; Deoxycytidine; DNA; Granulocytes; Humans; Idoxuridine; Kinetics; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Macrophages; Thymidine; Thymidine Kinase | 1983 |
Potential pre-screening for therapeutic agents that induce differentiation in human myeloid leukemia cells.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Cell Line; Cell Transformation, Neoplastic; Complement C3; Cytarabine; Dactinomycin; Doxorubicin; Humans; Hydroxyurea; Immunoglobulin Fc Fragments; Leukemia, Myeloid; Leukocytes; Mitomycins; Muramidase; Rosette Formation | 1980 |
Culture of bone marrow reveals more cells with chromosomal abnormalities than the direct method in patients with hematologic disorders.
Topics: Acute Disease; Adolescent; Adult; Aged; Anemia, Sideroblastic; Bone Marrow Cells; Bromodeoxyuridine; Cells, Cultured; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Clone Cells; Female; Hematologic Diseases; Humans; Leukemia; Leukemia, Myeloid; Lymphoma; Male; Middle Aged; Mitosis; Multiple Myeloma; Polycythemia Vera; Preleukemia | 1981 |
A macrolide antibiotic, roxithromycin, inhibits the growth of human myeloid leukemia HL60 cells by producing multinucleate cells.
Topics: Bromodeoxyuridine; Cell Division; Cell Line; Cell Nucleus; DNA, Neoplasm; Dose-Response Relationship, Drug; Flow Cytometry; Growth Inhibitors; Humans; Leukemia, Myeloid; Roxithromycin; Time Factors | 1995 |
Novel in situ double labeling for simultaneous detection of proliferation and apoptosis.
Topics: Acute Disease; Apoptosis; Bone Marrow; Bromodeoxyuridine; Cell Division; DNA; DNA, Neoplasm; Hematopoietic Stem Cells; Humans; Idoxuridine; Leukemia, Myeloid; Myelodysplastic Syndromes; S Phase | 1994 |
Clinical and prognostic significance of in vivo differentiation in acute myeloid leukemia.
Topics: Acute Disease; Antibodies, Monoclonal; Biopsy, Needle; Bone Marrow; Bromodeoxyuridine; Cell Cycle; Cell Differentiation; Cell Division; Cytarabine; Daunorubicin; Drug Therapy, Combination; Granulocytes; Humans; Leukemia, Myeloid; Prognosis; Remission Induction; Risk Factors | 1993 |
Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation.
Topics: Antimetabolites; Apoptosis; Bromodeoxyuridine; Cell Cycle; Cell Survival; Ceramides; DNA Fragmentation; DNA Repair; Humans; Hydrolysis; Leukemia, Myeloid; Sphingomyelin Phosphodiesterase; Tumor Cells, Cultured | 1998 |
Induction of differentiated functions which are reversibly suppressed by cytochalasin B.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Line; Cell Movement; Culture Media; Cytarabine; Cytochalasin B; Depression, Chemical; Floxuridine; Latex; Leukemia, Myeloid; Mice; Mice, Inbred Strains; Microspheres; Mitosis; Phagocytosis; Polystyrenes; Radiation Effects; Trypsin; X-Rays | 1975 |
Control of normal differentiation of myeloid leukemic cells. VI. Inhibition of cell multiplication and the formation of macrophages.
Topics: Animals; Blood; Bromodeoxyuridine; Cell Adhesion; Cell Differentiation; Cell Division; Cell Movement; Clone Cells; Cycloheximide; Cytarabine; Dactinomycin; Endotoxins; Floxuridine; Hydroxyurea; Idoxuridine; Leukemia, Myeloid; Macrophages; Mice; Mitomycins; Thymidine; Vinblastine | 1975 |
Requirements for RNA and protein synthesis in the induction of several differentiation-markers in a myeloid leukemia cell line.
Topics: Animals; Bromodeoxyuridine; Cell Differentiation; Cell Line; Cell Movement; Drug Resistance; Immunoglobulin Fc Fragments; Leukemia, Experimental; Leukemia, Myeloid; Neoplasm Proteins; Phagocytosis; RNA, Neoplasm | 1979 |
Purification of BrdUrd-substituted DNA by immunoaffinity chromatography with anti-BrdUrd antibodies.
Topics: Antibodies; Bromodeoxyuridine; Chromatography, Affinity; DNA; Humans; Leukemia, Myeloid; Tumor Cells, Cultured | 1992 |
Washless double staining of unfixed nuclei for flow cytometric analysis of DNA and a nuclear antigen (Ki-67 or bromodeoxyuridine).
Topics: Bromodeoxyuridine; Cell Nucleus; DNA; DNA, Neoplasm; Flow Cytometry; Humans; Ki-67 Antigen; Leukemia, Myeloid; Lymphocytes; Nuclear Proteins; Staining and Labeling | 1991 |
In vivo effect of granulocyte-macrophage colony-stimulating factor on the kinetics of human acute myeloid leukemia cells.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bromodeoxyuridine; Cell Cycle; Female; Fluorescent Antibody Technique; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Humans; Leukemia, Myeloid; Leukocyte Count; Male; Remission Induction | 1991 |
Observations regarding DNA replication sites in human cells in vivo following infusions of iododeoxyuridine and bromodeoxyuridine.
Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Nucleus; DNA Replication; Gastrointestinal Neoplasms; Humans; Idoxuridine; Immunoenzyme Techniques; Leukemia; Leukemia, Myeloid; Neoplasms; S Phase | 1991 |
Enhanced expression of chromosome fragile site 10q25 in chronic myelogenous leukemia.
Topics: Bone Marrow; Bromodeoxyuridine; Chromosome Banding; Chromosome Fragile Sites; Chromosome Fragility; Chromosomes, Human, 21-22 and Y; Chromosomes, Human, 6-12 and X; Female; Gene Expression Regulation; Humans; Leukemia, Myeloid; Lymphocytes; Middle Aged | 1985 |
In vitro and in vivo assessment of sensitivity to ara-C in myeloid leukemias.
Topics: Adult; Aged; Bone Marrow; Bromodeoxyuridine; Cytarabine; DNA; Drug Resistance; Female; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Interphase; Leukemia; Leukemia, Myeloid; Male; Middle Aged | 1985 |